Quad Cities Investment Group, LLC Tekla Life Sciences Investors Transaction History

Quad Cities Investment Group, LLC

$196 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	BUY	$12.38 - $13.69 $125,582 - $138,871	10,144 New	10,144 $126,000
Q1 2023 Apr 20, 2023	SELL	$13.37 - $14.94 $7,219 - $8,067	-540 Reduced 5.06%	10,137 $141,000
Q4 2022 Feb 14, 2023	BUY	$13.55 - $15.23 $2,981 - $3,350	220 Added 2.1%	10,677 $151,000
Q3 2022 Nov 14, 2022	SELL	$13.39 - $16.31 $5,771 - $7,029	-431 Reduced 3.96%	10,457 $143,000
Q2 2022 Aug 08, 2022	BUY	$13.11 - $17.02 $3,500 - $4,544	267 Added 2.51%	10,888 $155,000
Q1 2022 May 06, 2022	BUY	$15.35 - $19.29 $506 - $636	33 Added 0.31%	10,621 $176,000
Q4 2021 Feb 02, 2022	BUY	$18.5 - $21.59 $5,291 - $6,174	286 Added 2.78%	10,588 $204,000
Q3 2021 Nov 12, 2021	BUY	$20.27 - $22.67 $1,135 - $1,269	56 Added 0.55%	10,302 $214,000
Q2 2021 Aug 10, 2021	SELL	$19.14 - $21.44 $18,278 - $20,475	-955 Reduced 8.53%	10,246 $220,000
Q1 2021 Apr 29, 2021	BUY	$19.31 - $22.07 $216,291 - $247,206	11,201 New	11,201 $221,000
Q4 2020 Feb 10, 2021	SELL	$16.8 - $20.21 $180,516 - $217,156	-10,745 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$16.71 - $19.06 $33 - $38	2 Added 0.02%	10,745 $189,000
Q2 2020 Aug 05, 2020	BUY	$14.22 - $18.38 $2,787 - $3,602	196 Added 1.86%	10,743 $193,000
Q1 2020 May 11, 2020	BUY	$12.22 - $17.99 $3,898 - $5,738	319 Added 3.12%	10,547 $158,000
Q4 2019 Jan 28, 2020	BUY	$14.63 - $17.84 $2,691 - $3,282	184 Added 1.83%	10,228 $179,000
Q3 2019 Oct 25, 2019	SELL	$15.09 - $17.09 $13,083 - $14,817	-867 Reduced 7.95%	10,044 $1.52 Million
Q2 2019 Jul 17, 2019	BUY	$15.54 - $17.47 $3,636 - $4,087	234 Added 2.19%	10,911 $185,000
Q1 2019 Apr 09, 2019	SELL	$15.5 - $17.9 $992 - $1,145	-64 Reduced 0.6%	10,677 $182,000
Q4 2018 Feb 06, 2019	BUY	$13.99 - $20.35 $3,623 - $5,270	259 Added 2.47%	10,741 $162,000
Q3 2018 Oct 18, 2018	BUY	$18.89 - $20.49 $4,212 - $4,569	223 Added 2.17%	10,482 $215,000
Q2 2018 Aug 07, 2018	SELL	$18.13 - $19.4 $32,851 - $35,152	-1,812 Reduced 15.01%	10,259 $193,000
Q1 2018 May 23, 2018	BUY	$18.92 - $21.52 $228,383 - $259,767	12,071 New	12,071 $233,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.31M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$46.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.5 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.61 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.33 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.63 Million
0.14% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quad Cities Investment Group, LLC with notifications on news.

Account